重新评估单基因扩张型心肌病的遗传贡献
该研究对1040例DCM患者和912例健康对照进行56个候选基因测序,并结合1498例诊断实验室患者和Exome Aggregation Consortium数据验证,发现TTN和DSP截短变异在所有比较中与DCM相关,另有10个基因在特定亚组中富集,这12个基因可解释门诊队列17%和诊断转诊队列26%的病例。
要点
- TTN和DSP截短变异在所有比较中均与DCM显著相关。
- 12个基因的罕见变异可解释门诊DCM队列17%的病例。
- 其他测试基因诊断价值有限,新型变异难以解读。
核心结论
- 在迄今最大测序DCM队列中,12个基因与DCM稳健关联,具有高诊断可解释性。
- 其他分析基因需严格评估作为孟德尔DCM基因的有效性,目前诊断测试价值有限。
研究设计与样本
- 使用TruSight Cardio测序面板评估1040例DCM患者和912例健康对照的56个候选基因罕见变异负荷。
- 汇总1498例诊断实验室DCM患者和Exome Aggregation Consortium数据库数据进行复制和荟萃分析。
主要发现
- TTN和DSP截短变异在所有比较中与DCM相关。
- MYH7、LMNA、BAG3、TNNT2、TNNC1、PLN、ACTC1、NEXN、TPM1和VCL在特定患者亚组中显著富集,其中TPM1和VCL可能主要贡献于早发型DCM。
- 12个基因的罕见变异可解释门诊队列17%和诊断转诊队列26%的DCM病例。
临床怎么用
- 临床诊断测试应优先检测TTN、DSP等12个稳健关联基因,以提高诊断可解释性。
- 对于其他候选基因的新变异,应谨慎解读,因其诊断产出极低。
局限性
- 其他基因缺乏显著过量不能排除其在疾病中的有限作用。
- 研究基于特定测序面板和数据库,可能受人群背景变异影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dilated cardiomyopathy (DCM) is genetically heterogeneous, with >100 purported disease genes tested in clinical laboratories. However, many genes were originally identified based on candidate-gene studies that did not adequately account for background population variation. Here we define the frequency of rare variation in 2538 patients with DCM across protein-coding regions of 56 commonly tested genes and compare this to both 912 confirmed healthy controls and a reference population of 60 706 individuals to identify clinically interpretable genes robustly associated with dominant monogenic DCM. METHODS: We used the TruSight Cardio sequencing panel to evaluate the burden of rare variants in 56 putative DCM genes in 1040 patients with DCM and 912 healthy volunteers processed with identical sequencing and bioinformatics pipelines. We further aggregated data from 1498 patients with DCM sequenced in diagnostic laboratories and the Exome Aggregation Consortium database for replication and meta-analysis. RESULTS: Truncating variants in TTN and DSP were associated with DCM in all comparisons. Variants in MYH7, LMNA, BAG3, TNNT2, TNNC1, PLN, ACTC1, NEXN, TPM1, and VCL were significantly enriched in specific patient subsets, with the last 2 genes potentially contributing primarily to early-onset forms of DCM. Overall, rare variants in these 12 genes potentially explained 17% of cases in the outpatient clinic cohort representing a broad range of adult patients with DCM and 26% of cases in the diagnostic referral cohort enriched in familial and early-onset DCM. Although the absence of a significant excess in other genes cannot preclude a limited role in disease, such genes have limited diagnostic value because novel variants will be uninterpretable and their diagnostic yield is minimal. CONCLUSIONS: In the largest sequenced DCM cohort yet described, we observe robust disease association with 12 genes, highlighting their importance in DCM and translating into high interpretability in diagnostic testing. The other genes analyzed here will need to be rigorously evaluated in ongoing curation efforts to determine their validity as Mendelian DCM genes but have limited value in diagnostic testing in DCM at present. This data will contribute to community gene curation efforts and will reduce erroneous and inconclusive findings in diagnostic testing.
引用
- Mazzarotto F, Tayal U, Buchan RJ, et al. Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy. Circulation. 2020. PMID: 31983221. doi:10.1161/CIRCULATIONAHA.119.037661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。